The US Food and Drug Administration (FDA) recently issued draft guidance with recommendations to help clinical trial sponsors determine when a data monitoring committee (DMC) would be beneficial for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback